scout

Jason Westin, MD, The University of Texas MD Anderson Cancer Center

Articles by Jason Westin, MD, The University of Texas MD Anderson Cancer Center

Expert on DLBCL

Diffuse Large B-Cell Lymphoma: Moving Novel Therapy to the Frontline Setting

ByMatthew A. Lunning, DO, FACP, University of Nebraska Medical Center,Joanna M. Rhodes, MD, MSCE,Yucai Wang, MD, PhD, Mayo Clinic,Jason Westin, MD, The University of Texas MD Anderson Cancer Center,Ian W. Flinn, MD, PhD, Sarah Cannon Research Institute,Hayder M. Saeed, MD, Moffitt Cancer Center

Expert perspectives on recent efforts to move novel therapy from the relapsed/refractory to frontline setting of diffuse large B-cell lymphoma.

Latest Updated Articles